GSK-200858

Study Sponsor: GSK

Study Title

A Phase I Open-label, Dose Escalation Study to Investigate The Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2879552 Given Orally in Subjects with Relapsed/Refractory Small Cell Lung Carcinoma

Medicine or Vaccine (generic name)

GSK2879552

Sponsor Identification Number

200858

Trial Registry Identification Number(#'s)

NCT02034123 2013-003451-38

Medical Condition

Carcinoma, Small Cell

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200858

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02034123

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2013-003451-38

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2019